Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18070856 | 0.88 | BLM (0.61) | BLMCHRM2CHRM3HPGDALDH1A1 | |
| SCHEMBL9928310 | 0.83 | BLM (0.51) | BLMCYP2C9SMN1; SMN2MAPK1HIF1A | |
| SCHEMBL9899355 | 0.82 | CHRM2 (0.50) | BLMCYP2C9SMN1; SMN2MAPK1HIF1A | |
| SCHEMBL9898356 | 0.79 | MEN1 (0.56) | BLMMAPK1ALDH1A1MEN1KMT2A | |
| SCHEMBL14427028 | 0.78 | BLM (0.59) | BLMCHRM2CHRM3HPGDALDH1A1 | |
| SCHEMBL9928306 | 0.78 | BLM (0.59) | BLMCHRM2CHRM3HPGDALDH1A1 | |
| SCHEMBL9228370 | 0.77 | CHRM2 (0.46) | BLMCYP2C9SMN1; SMN2MAPK1HIF1A | |
| SCHEMBL9233702 | 0.76 | CHRM2 (0.45) | BLMCYP2C9SMN1; SMN2MAPK1HIF1A | |
| SCHEMBL13471656 | 0.75 | ACHE (0.47) | BLMCYP2C9SMN1; SMN2MAPK1HIF1A | |
| SCHEMBL9928309 | 0.74 | HPGD (0.61) | BLMMAPK1CHRM2CHRM3HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120149902-A1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE | UBE INDUSTRIES, LTD. (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149902-A1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE | ERBB2, EGFR, FGFR1 | BLM 4374/4885CYP2C9 1769/4885SMN1; SMN2 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.